GLP-1 Product Enablement Specialist
A company is looking for a GLP-1 Product Enablement specialist. Key Responsibilities Design and deliver training for the GLP-1 product line, ensuring competency across the commercial team Collaborate with Commercial and Clinical leaders to identify knowledge gaps and enhance selling tools Develop strategies and playbooks for new product introductions and pipeline creation Required Qualifications 7+ […]
Is GLP-1 the new AI? Drugmaker Eli Lilly joins the $1 trillion market-cap club.
Post Content
Eli Lilly becomes first health-care company to hit $1 trillion
Silicon Valley’s giants crowd the list of the world’s most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of one trillion dollars on Friday, becoming the first business in the health industry to hit that milestone. Lilly’s achievement comes during a tense week for stock watchers. […]
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care to hit the milestone.
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates as a connected healthcare platform rather than a single-product provider, consistently linking consumers with licensed clinicians, diagnostics and pharmaceutical partners. The company’s model is built around provider-guided evaluations, personalized treatment plans and integrated pharmacy fulfillment — an ecosystem designed to coordinate care […]
Orangetheory Rebuilds Its Message Around Real Women
A new campaign centers member stories as GLP-1 drugs, menopause awareness and strength trends reshape the fitness landscape.
Prescription Weight Loss Drugs: Which Weight Loss Drug Is Best?
Compare the newest GLP-1 drugs (Wegovy, Zepbound) with older medications. Learn about side effects, cost and how to work with your doctor to find the best prescription weight loss drug for your health and long-term goals
Novo, Lilly begin to sell obesity medications directly to employers
Building on the growing success of offering cheaper cash-pay prices to consumers for their GLP-1 weight loss drugs, Novo Nordisk and Eli Lilly are setting up programs to work directly with employers. Waltz Health, an …
Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joins the $1 trillion market-cap club.
Eli Lilly on Friday briefly crossed the $1 trillion market-cap threshold, the first drugmaker to ever reach that milestone.
Inside Europe’s AI-Fuelled GLP-1 Scam Epidemic: How Criminal Networks Are Hijacking the Identities of the NHS, AEMPS, ANSM, BfArM and AIFA to Sell Fake Weight-Loss Products
The global appetite for GLP-1 medications like Ozempic, Wegovy and Mounjaro have created something far more dangerous than a cultural trend. It has created the perfect opening for cyber criminals who understand how desperation, scarcity and online misinformation intersect. As clinics struggle with shortages and manufacturers warn of supply limits extending well into 2025 and […]